Cold Plasma Market
                     Cold Plasma 
Market
© P&S Intelligence. All Rights Reserved 1
The total value of the global cold plasma market was USD,846 million in 2022, and it will rise at 
a growth rate of above 14.80% in the near future, to reach USD 5,568 million by 2030, 
according to P&S Intelligence. This can be credited to the profits of the cold plasma technology 
for a count of applications, including wound remedial, and the improvements in it.
In 2022, the polymer and plastic category held the largest market share, of above 32%. This can 
be credited to the fact that plastic and polymer applications need solid surface adherence to get 
the finest mechanical functionality and extended lifespan of plastic components.
Request for sample pages of this report: https://www.psmarketresearch.com/market-
analysis/cold-plasma-market/report-sample
Observing the flared application of this technology in the polymer and plastic market, numerous 
key companies have started introducing systems and devices that permit this industry to utilize 
it.
Atmospheric cold plasma had the larger market share of the cold plasma market, credited to its 
utilization in numerous applications.
For example, it has shown promising outcomes in eczema treatment. Scientists from the 
Institute of Plasma Physics Chinese Academy of Sciences utilized an animal prototype to 
validate the possibilities of this technology in the cure of eczema with no side-effect. There is no 
treatment for atopic dermatitis, in simple words eczema, to date; it can be only managed with 
appropriate care.
© P&S Intelligence. All Rights Reserved 2
In the coming few years, the wound healing category is projected to witness the highest revenue CAGR, of 
15.4%. This is due to scientists having been utilizing cold plasma to accelerate the curing of exterior wounds 
for some time now. This method depends on making a high-voltage drop between a special device called the 
plasmodesma and the skin.
In 2022, North America dominated the market with the largest market share, 44%, it is projected to advance 
with a significant CAGR in the coming few years. This is mainly because of the surge in healthcare spending 
and Research and development activities.
Browse full report at: https://www.psmarketresearch.com/market-analysis/cold-plasma-market
For example, in March 2022, Jerome Canady Research Institute for Advanced Biological and Technological 
Sciences (JCRI-ABTS) issued a report on how a blend of the Canady Helios cold plasma and anti-BCL2A1 
treatments might be helpful for patients suffering from breast cancer and other solid tumors.
Furthermore, the U.S. government has augmented its budget for cancer research. The Consolidated 
Appropriations Act, of 2023 has assigned USD 7.2 billion to the NCI, which was a USD 408 million rise over 
the FY 2022 funding, with USD 216 million for the characteristics of the Cancer Moonshot program being 
supervised by the NCI.
Hence, the profits of the cold plasma technology for a count of applications, including wound remedial, and 
the improvements in it, are the major factors driving the cold plasma market.
© P&S Intelligence. All Rights Reserved 3
Disclaimer: 
P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of 
information and data 
provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from 
various companies 
or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. the information or analysis 
in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to 
be correct at the time of publication, 
but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. 
All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can 
these be reproduced 
in any form without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No 
service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or 
form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written 
permission from Prescient & Strategic Intelligence Pvt. Ltd.
For queries related to sales, contact 
us aetn:[email protected]
US/Canada Toll-Free: 1-888-778-
To know more about us, visit our 
7886
webspitsemarketresearch.com International: +1-347-960-6455
India: +91 120 4541 337
© P&S Intelligence. All Rights Reserved 4